Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Clinical trial NCT06988605 · RECRUITING
Trial details
- NCT number
- NCT06988605
- Sponsor
- Galderma R&D
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-14
- Primary completion
- 2026-11-06
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.